Skip to main content
Toggle navigation
Search
Home
Browse by Speaker
Home
Browse by Speaker
Browse by Speaker
Type here to filter the list
All
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
W
Wei, Rongfang
Department of Hematology, The Eighth Affiliated Hospital, Sun Yat-sen University
(PA-324) AKR1B1/NAT10 Mediate IL4I1 ac4C Modification to Regulate Tryptophan Metabolism and Promote Multiple Myeloma Proliferation
Location: Room 714A
Rongfang Wei
Weisel, Katja
University Medical Center of Hamburg-Eppendorf, Hamburg, Germany
Functional high risk patients at relapse
Location: Hall FG
Katja Weisel
Wiedmeier-Nutor, Julia
Mayo Clinic
(OA-26) Comparative Analysis of ClonoSEQ MRD Testing from Bone Marrow and Circulating Tumor DNA Assessment in Multiple Myeloma
Location: Room 718
Julia Wiedmeier-Nutor
Winterberg, Dorothee
University Medical Center Schleswig-Holstein
(OA-37) Novel NKp30-directed Bispecific Natural Killer Cell Engagers Targeting GPRC5D or CD38 for the Treatment of Multiple Myeloma
Location: Room 718
Dorothee Winterberg
Wong, Daniel
Alfred Health
(OA-45) Cell-Free BCL2 exRNA, but not MYC or MIZ1, Identifies Smouldering Myeloma with a High Risk of Progression among Patients in the Myeloma Related Disease Registry (MRDR)
Location: Room 718
Daniel Wong
